118 related articles for article (PubMed ID: 37767635)
1. The potential of exome sequencing of paired colorectal tumors and synchronous liver metastases to improve treatment.
Hlaváč V; Holý P; Souček P
Pharmacogenomics; 2023 Aug; 24(13):697-699. PubMed ID: 37767635
[TBL] [Abstract][Full Text] [Related]
2. Exome Sequencing of Paired Colorectal Carcinomas and Synchronous Liver Metastases for Prognosis and Therapy Prediction.
Hlaváč V; Červenková L; Šůsová S; Holý P; Liška V; Vyčítal O; Šorejs O; Fiala O; Daum O; Souček P
JCO Precis Oncol; 2023 May; 7():e2200557. PubMed ID: 37141551
[TBL] [Abstract][Full Text] [Related]
3. Necessity of Genetic Evaluation of Metachronous Metastases of Colorectal Cancer: Quantitative Analysis of Genetic Discordance Between Metachronous Metastases and Radically Resected Primary Colorectal Cancers Using Next-Generation Sequencing.
Lee KH; Kim JS; Kim JY
Dis Colon Rectum; 2019 Jul; 62(7):832-839. PubMed ID: 31188184
[TBL] [Abstract][Full Text] [Related]
4. Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
Kovaleva V; Geissler AL; Lutz L; Fritsch R; Makowiec F; Wiesemann S; Hopt UT; Passlick B; Werner M; Lassmann S
Mol Cancer; 2016 Oct; 15(1):63. PubMed ID: 27756406
[TBL] [Abstract][Full Text] [Related]
5. Prognostic potential of whole exome sequencing in the clinical management of metachronous colorectal cancer liver metastases.
Heczko L; Hlaváč V; Holý P; Dvořák P; Liška V; Vyčítal O; Fiala O; Souček P
Cancer Cell Int; 2023 Nov; 23(1):295. PubMed ID: 38008721
[TBL] [Abstract][Full Text] [Related]
6. Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases.
Zheng P; Ren L; Feng Q; Zhu D; Chang W; He G; Ji M; Jian M; Lin Q; Yi T; Wei Y; Xu J
Cancer Manag Res; 2018; 10():2871-2881. PubMed ID: 30214282
[TBL] [Abstract][Full Text] [Related]
7. Exome sequencing of synchronously resected primary colorectal tumours and colorectal liver metastases to inform oncosurgical management.
Sutton PA; Jithesh PV; Jones RP; Evans JP; Vimalachandran D; Malik HZ; Park BK; Goldring CE; Palmer DH; Kitteringham NR
Eur J Surg Oncol; 2018 Jan; 44(1):115-121. PubMed ID: 29174709
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Survival in Synchronous and Metachronous Liver Metastases From Colorectal Cancer.
Reboux N; Jooste V; Goungounga J; Robaszkiewicz M; Nousbaum JB; Bouvier AM
JAMA Netw Open; 2022 Oct; 5(10):e2236666. PubMed ID: 36239935
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and molecular features between synchronous and metachronous metastases in colorectal cancer.
Lan YT; Chang SC; Lin PC; Lin CC; Lin HH; Huang SC; Lin CH; Liang WY; Chen WS; Jiang JK; Yang SH; Lin JK
Am J Cancer Res; 2021; 11(4):1646-1658. PubMed ID: 33948379
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features and prognosis in resectable synchronous and metachronous colorectal liver metastasis.
Tsai MS; Su YH; Ho MC; Liang JT; Chen TP; Lai HS; Lee PH
Ann Surg Oncol; 2007 Feb; 14(2):786-94. PubMed ID: 17103254
[TBL] [Abstract][Full Text] [Related]
11. The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review.
Slesser AA; Georgiou P; Brown G; Mudan S; Goldin R; Tekkis P
Clin Exp Metastasis; 2013 Apr; 30(4):457-70. PubMed ID: 23180209
[TBL] [Abstract][Full Text] [Related]
12. KRAS, NRAS, PIK3CA exon 20, and BRAF genotypes in synchronous and metachronous primary colorectal cancers diagnostic and therapeutic implications.
Balschun K; Haag J; Wenke AK; von Schönfels W; Schwarz NT; Röcken C
J Mol Diagn; 2011 Jul; 13(4):436-45. PubMed ID: 21704278
[TBL] [Abstract][Full Text] [Related]
13. KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness in Synchronous Metastatic Colorectal Cancer (mCRC): Retrospective Research.
He K; Wang Y; Zhong Y; Pan X; Si L; Lu J
Onco Targets Ther; 2020; 13():12601-12613. PubMed ID: 33335401
[TBL] [Abstract][Full Text] [Related]
14. A specific KRAS codon 13 mutation is an independent predictor for colorectal cancer metachronous distant metastases.
Feng Q; Liang L; Ren L; Chen J; Wei Y; Chang W; Zhu D; Lin Q; Zheng P; Xu J
Am J Cancer Res; 2015; 5(2):674-88. PubMed ID: 25973306
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Mutation Profiling of Colorectal Cancer Patients With Lung or Liver Metastasis by Targeted Next-Generation Sequencing.
Hu CT; Wang JL; Hou T; Yan ZW; Zu LD; Fu GH; Shen WW
Technol Cancer Res Treat; 2023; 22():15330338231185285. PubMed ID: 37394872
[TBL] [Abstract][Full Text] [Related]
16. [Impact of time of occurrence of liver metastases (synchronous vs. metachronous) on early postoperative outcome and long-term survival of colorectal cancer patients].
Bova R; Kamphues C; Neuhaus P; Puhl G
Zentralbl Chir; 2014 Apr; 139(2):220-5. PubMed ID: 23846535
[TBL] [Abstract][Full Text] [Related]
17. METACHRONOUS COLORECTAL LIVER METASTASES HAS BETTER PROGNOSIS - IS IT TRUE?
Quireze Junior C; Brasil AMS; Morais LK; Campion ERL; Taveira EJF; Rassi MC
Arq Gastroenterol; 2018; 55(3):258-263. PubMed ID: 30540088
[TBL] [Abstract][Full Text] [Related]
18. Comparison of KRAS and PIK3CA gene status between primary tumors and paired metastases in colorectal cancer.
He Q; Xu Q; Wu W; Chen L; Sun W; Ying J
Onco Targets Ther; 2016; 9():2329-35. PubMed ID: 27143928
[TBL] [Abstract][Full Text] [Related]
19. The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer.
Huang CW; Tsai HL; Chen YT; Huang CM; Ma CJ; Lu CY; Kuo CH; Wu DC; Chai CY; Wang JY
BMC Cancer; 2013 Dec; 13():599. PubMed ID: 24330663
[TBL] [Abstract][Full Text] [Related]
20. A preliminary analysis of combined liver resection with new chemotherapy for synchronous and metachronous colorectal liver metastasis.
Ng WW; Cheung YS; Wong J; Lee KF; Lai PB
Asian J Surg; 2009 Oct; 32(4):189-97. PubMed ID: 19892621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
